Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 17
Patient Perceptions of Switching to a Generic Dry Powder Inhaler – Increased Understanding Through Journey Mapping [Corrigendum]
Authors Ray SE , Boudewyns V, Davis C, Tzeng JP, Srivastava I, Oguntimein O, Conti DS, Feibus KB
Received 20 September 2022
Accepted for publication 20 September 2022
Published 25 September 2022 Volume 2022:17 Pages 2381—2382
Ray SE, Boudewyns V, Davis C, et al. Int J Chron Obstruct Pulmon Dis. 2022;17:1751–1768.
The authors have advised that the Disclosure section on page 1766 is incorrect. The following text should have been included.
“This research was funded by contract HHSF223201810113C from the Office of Research and Standards/Office of Generic Drugs, U.S. Food and Drug Administration”.
The authors apologize for this error.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.